CHS Trims 2026 Outlook as Payer Mix Weakens and Surgery Volumes Slump
Community Health Systems is entering 2026 with a thinner financial cushion and a more difficult patient mix. The hospital operator lowered its full-year earnings outlook after uninsured volumes rose and patients deferred higher-margin elective procedures, especially orthopedic and general surgeries. Those two pressures converged in the third quarter and pushed the company into the red, with an $86 million loss compared with a $130 million profit in the same period a year earlier.
The earnings reset reflects more than a temporary demand wobble. It points to a payer-mix shift that directly erodes hospital margins: more uninsured emergency visits at the bottom end of reimbursement, fewer commercially insured surgical cases at the top end. In a fee-for-service business, that combination is difficult to absorb. It leaves hospitals doing more care that is harder to collect on while losing some of the most profitable procedures they typically rely on to offset fixed costs.
CHS now expects adjusted pretax earnings of $1.2 billion to $1.3 billion for the year, down from a prior forecast of $1.3 billion to $1.4 billion. Operating revenue fell to $2.8 billion, down 10% year over year. The company also said uninsured patients linked to Affordable Care Act coverage losses cost it as much as $35 million in the quarter, and it now projects a full-year hit of $80 million to $90 million from the subsidy expiration.
Elective Surgery Deferral Is Hitting the Highest-Margin Cases
A 2% year-over-year increase in same-store surgeries would normally suggest some stability, but the mix beneath that headline tells a different story. CHS saw fewer high-margin patients in elective orthopedic and general surgeries, which are the types of cases most vulnerable to cost-conscious delay. Patients with commercial insurance, who usually generate the strongest reimbursement, declined, and same-store revenue per adjusted admission was flat.
One sentence captures the problem: the cases that vanished were the ones that paid best.
Chief Executive Kevin Hammons tied the weakness to patient behavior rather than physician referral patterns or capacity constraints. Elective procedures, he said, are being pushed out because patients are making financial decisions about care. In practical terms, that means a knee replacement, hernia repair, or similar operation may stay on the calendar in theory while slipping out several quarters in practice. For a hospital system, the revenue effect is immediate even if the underlying medical need remains unchanged.
Hammons also argued that demand is not gone, only delayed. He described the backlogged procedures as pent-up volume that should eventually return because a joint replacement does not heal on its own. The biological reality is straightforward: degenerative joint disease, chronic pain, and functional loss do not resolve because a patient postpones surgery. But the hospital balance sheet still absorbs the gap in the meantime, and CHS is not capturing that deferred activity as efficiently as some peers.
Rising Uninsured Use Is Replacing Better-Paid Utilization
At the same time elective procedures softened, uninsured volumes moved in the opposite direction. Hammons said the increase began ramping up in the second quarter, and patients are now appearing in emergency departments for lower-acuity conditions that could often be managed in primary care if insurance coverage were intact. Nearly half of CHS’s 3.6% growth in adjusted admissions came from uninsured patients, according to Chief Financial Officer Jason Johnson.
That shift is especially costly because it increases bad debt and uncompensated care. Jefferies estimated uncompensated care rose to 32.9% of adjusted net revenue, up from 25.2% in the prior-year period. The mechanics are familiar across hospital finance: when coverage drops, collections fall, charity care rises, and the billing profile tilts toward lower yield. In CHS’s case, executives have linked part of the pressure to patients who lost ACA coverage after enhanced subsidies expired last year.
The company has repeatedly undercounted the damage from that policy change. CHS first expected a loss of $20 million to $30 million, then raised the outlook in July to $50 million to $75 million, and now projects an $80 million to $90 million hit for the year. Each revision suggests the same underlying problem is proving broader and more persistent than management initially anticipated.
For-Profit Hospitals Are Facing the Same Two-Sided Squeeze
CHS is not dealing with an isolated pattern. Other for-profit hospital chains have flagged the same combination of deferred surgeries and rising uninsured utilization this year. Universal Health Services has also been affected, while Tenet Healthcare has been better able to absorb the decline by shifting more volume into higher-acuity surgical cases. CHS, by contrast, has not captured that offset with the same effectiveness.
The distinction matters because higher-acuity surgical work can partially shield hospitals from softer elective demand. Complex procedures tend to carry stronger reimbursement and can help compensate for slower case flow elsewhere. CHS’s quarterly results suggest it is not benefiting from that buffer to the same degree. Instead, it is experiencing the negative side of the cycle first: less commercial surgical revenue, more uninsured emergency care, and rising uncompensated costs.
This is where hospital finance becomes a proxy for access. When patients cannot afford coverage or delay surgery because of out-of-pocket pressure, the medical need does not disappear. It migrates to the emergency department, becomes more expensive to manage, and arrives on a weaker payment footing. The result is visible in CHS’s margins, but the mechanism starts much earlier, in delayed care and insurance loss.
The Near-Term Question Is How Long Deferred Demand Stays Deferred
Hammons expressed confidence that surgeries will return, but the timing and pace of recovery remain uncertain. If patients continue to delay elective care while uninsured volumes stay elevated, CHS could face another year of margin pressure even if overall admissions hold up. A hospital can only absorb so much bad debt before revenue growth stops translating into profit.
The quarter also exposed how sensitive hospital earnings are to policy-driven shifts in coverage. Enhanced ACA subsidies ending last year did not just affect enrollment; they altered where patients seek care, what type of care they seek, and how hospitals are paid for it. For CHS, those changes were large enough to force a guidance cut, a swing to a quarterly loss, and a much heavier uncompensated-care burden than it carried a year ago.
The next readout that will matter most is whether the elective backlog returns in a way that restores commercial mix, or whether uninsured volumes keep filling beds first. Until that balance changes, the company’s recovery will depend less on raw admission counts than on who is walking through the door and what kind of care they need.